From the International Innovation Journal. Download the original article here. Professor Andrew Boyd, Head of the Leukaemia Foundation Research Unit at QIMR, has been studying EphA3 – a gene not normally active in blood cells, but highly expressed in a number of leukaemias and lymphomas. The journey from the initial identification of the antibody to […]